# FDA Inspection 1007051 - ReproTech, LTD. - March 07, 2017

Source: https://www.keypedia.com/records/fda_inspections/reprotech-ltd/d0539a90-d554-4b15-aa87-2cc07fcec3da
Source feed: FDA_Inspections

> FDA Inspection 1007051 for ReproTech, LTD. on March 07, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1007051
- Company Name: ReproTech, LTD.
- Inspection Date: 2017-03-07
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1162418 - 2022-02-14](https://www.keypedia.com/records/fda_inspections/reprotech-ltd/5310f947-b32a-4309-8ab3-c5fe2ff10ab1)
- [FDA Inspection 1162418 - 2022-02-14](https://www.keypedia.com/records/fda_inspections/reprotech-ltd/f8ed2887-0852-4a73-8f33-c50e92598bff)
- [FDA Inspection 853399 - 2013-10-30](https://www.keypedia.com/records/fda_inspections/reprotech-ltd/af9242c7-0001-4313-ab4d-7065265b5bc6)

Company: https://www.keypedia.com/companies/reprotech-ltd/ef8d2532-54bc-4933-bf98-aca2869348ea

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d